Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models
Pam Albaugh(Genomics Institute of the Novartis Research Foundation), Valentina Molteni(Genomics Institute of the Novartis Research Foundation), Yi Fan(Huaqiao University), Donald S. Karanewsky(Genomics Institute of the Novartis Research Foundation), Tami Hood(Genomics Institute of the Novartis Research Foundation), Jon C. Loren(Genomics Institute of the Novartis Research Foundation), Yelena Sarkisova(Genomics Institute of the Novartis Research Foundation), Shenlin Huang(Genomics Institute of the Novartis Research Foundation), Tove Tuntland(Genomics Institute of the Novartis Research Foundation), H. Martin Seidel(Genomics Institute of the Novartis Research Foundation), Andreas Kreusch(Genomics Institute of the Novartis Research Foundation), Zuosheng Liu, Min Lu(South China Agricultural University), Fangxian Sun(Genomics Institute of the Novartis Research Foundation), Yuan Mi(Unknown), Yong Jia(Harbin University of Science and Technology), Guoxun Liu(Genomics Institute of the Novartis Research Foundation), Francisco Adrián(HiFiBiO Therapeutics (United States)), Nanxin Li(Genomics Institute of the Novartis Research Foundation)
Cited by 96
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
|Proceedings of the National Academy of Sciences|2013|833
<i>In silico</i> activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
|Proceedings of the National Academy of Sciences|2008|454
Proteome Analysis of Hepatocellular Carcinoma by Two-dimensional Difference Gel Electrophoresis
|Molecular & Cellular Proteomics|2007|247